GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Yngve Falck-Ytter,Pablo Alonso-Coello,Holger J. Schünemann +6 more
Reads0
Chats0
TLDR
The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.Abstract:
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwideread more
Citations
More filters
Journal ArticleDOI
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production
Peter C. Collignon,Peter C. Collignon,John Conly,Antoine Andremont,S. A. McEwen,Awa Aidara-Kane,Yvonne Agerso,Peter Collignon,Peter Collignon,John Conly,Tran Dang Ninh,Pilar Donado-Godoy,Paula Fedorka-Cray,Heriberto Fernandez,Marcelo Galas,Rebecca Irwin,Beth Karp,Gassan Matar,Patrick McDermott,Scott A. McEwen,Eric Mitema,Richard Reid-Smith,H. Morgan Scott,Ruby Singh,Caroline Smith DeWaal,John Stelling,Mark Toleman,Haruo Watanabe,Gun-Jo Woo +28 more
TL;DR: The current large-scale use of fluoroquinolones, macrolides, and third-generation cephalosporins and any potential use of glycopeptides and carbapenems need to be addressed urgently.
Journal ArticleDOI
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
TL;DR: Recommendations are made for the investigation and management of aHUS patients both at presentation and in the long‐term, and particularly address the role of renal transplantation alone and combined liver‐kidney transplantation.
Journal ArticleDOI
American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism.
Paul Monagle,Carlos Cuello,Carlos Cuello,Caitlin Augustine,Mariana Bonduel,Leonardo R. Brandão,Tammy Capman,Anthony K.C. Chan,Sheila J. Hanson,Christoph Male,Joerg J Meerpohl,Fiona Newall,Sarah H. O'Brien,Leslie Raffini,Heleen van Ommen,John Wiernikowski,Suzan Williams,Meha Bhatt,John J. Riva,Yetiani Roldan,Nicole Schwab,Reem A. Mustafa,Reem A. Mustafa,Sara K. Vesely +23 more
TL;DR: Recommendations include understanding the natural history of asymptomatic thrombosis, determining subgroup boundaries that enable risk stratification of children for escalation of treatment, and appropriate study of newer anticoagulant agents in children.
Journal ArticleDOI
A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome
TL;DR: According to the quality of evidence only a weak recommendation for MBSR can be made at this point, and further high quality RCTs are required for a conclusive judgment of its effects.
Journal ArticleDOI
Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials
Long Ge,Long Ge,Behnam Sadeghirad,Geoff D.C. Ball,Bruno R. da Costa,Bruno R. da Costa,Christine L Hitchcock,Christine L Hitchcock,Anton Svendrovski,Ruhi Kiflen,Kalimullah Quadri,Henry Y. Kwon,Mohammad Karamouzian,Mohammad Karamouzian,Thomasin Adams-Webber,Waleed S. Ahmed,Samah Damanhoury,Dena Zeraatkar,Adriani Nikolakopoulou,Ross T. Tsuyuki,Jinhui Tian,Kehu Yang,Gordon H. Guyatt,Bradley C. Johnston,Bradley C. Johnston,Bradley C. Johnston +25 more
TL;DR: Overall, weight loss diminished at 12 months among all macronutrient patterns and popular named diets, while the benefits for cardiovascular risk factors of all interventions, except the Mediterranean diet, essentially disappeared.
References
More filters
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal ArticleDOI
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen B. Hulley,Deborah Grady,Trudy L. Bush,Curt D Furberg,David M. Herrington,Betty Riggs,Eric Vittinghoff +6 more
TL;DR: Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
Journal ArticleDOI
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Echt Ds,Philip R. Liebson,Mitchell Lb,Robert W. Peters,Obias-Manno D,Barker Ah,Arensberg D,Baker A,Lawrence S. Friedman,Greene Hl +9 more
TL;DR: There was an excess of deathsDue to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.
Journal ArticleDOI
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
TL;DR: Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a timely fashion need access to better databases and new statistical techniques to assist them.
Journal ArticleDOI
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
David Atkins,Martin P Eccles,Signe Flottorp,Gordon H. Guyatt,David Henry,Suzanne Hill,Alessandro Liberati,Dianne L. O'Connell,Andrew D Oxman,Bob Phillips,Holger J. Schünemann,Holger J. Schünemann,Tessa Tan-Torres Edejer,Gunn Elisabeth Vist,John W Williams +14 more
TL;DR: The objective was to critically appraise six prominent systems for grading levels of evidence and the strength of recommendations as a basis for agreeing on characteristics of a common, sensible approach.